Longitudinal assessment of renal perfusion and oxygenation in transplant donor-recipient pairs using arterial spin labeling and blood oxygen level-dependentmagnetic resonance imaging

Investigative Radiology

Volumn 51, Issue 2, 2016, Pages 113-120

  Niles, David J ^a   Artz, Nathan S ^a   Djamali, Arjang ^a   Sadowski, Elizabeth A ^a,b   Grist, Thomas M ^a,b   Fain, Sean B ^b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Wisconsin Electric Machines and Power Electronics Consortium   (United States)

Author keywords

Arterial spin labeling MRI; Blood oxygen level dependent MRI; Renal function; Renal transplant

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ATENOLOL; CLONAZEPAM; CLONIDINE; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; METOPROLOL; MYCOPHENOLIC ACID; NIFEDIPINE; PREDNISONE; PROPRANOLOL; SODIUM; TACROLIMUS; OXYGEN; SPIN LABEL;

ADULT; ARTICLE; BOLD SIGNAL; CONTROLLED STUDY; FEMALE; FRACTIONAL EXCRETION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY PERFUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; OXYGENATION; PRIORITY JOURNAL; SOLITARY KIDNEY; SPIN LABELING; BLOOD; BLOOD FLOW VELOCITY; CONTROLLED CLINICAL TRIAL; DONOR; KIDNEY ARTERY; KIDNEY CIRCULATION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; BLOOD FLOW VELOCITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; OXYGEN; RENAL ARTERY; RENAL CIRCULATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPIN LABELS; TISSUE DONORS; TRANSPLANT RECIPIENTS;

EID: 84953638172     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000210     Document Type: Article

References (54)

1. Landreneau K, Lee K, Landreneau MD. Quality of life in patients undergoing hemodialysis and renal transplantation-a meta-analytic review. Nephrol Nurs J. 2010;37:37-44.
2. Collins AJ, Foley RN, Chavers B, et al. 2013 USRDS annual data report-atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis. 2014;63:A1-A8, e1-e478.
3. Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 2006;70:1801-1810.
4. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006;145:185-196.
5. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med. 2009;360:459-469.
6. Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303:959-966.
7. Garg AX, Meirambayeva A, Huang A, et al. Cardiovascular disease in kidney donors: matched cohort study. BMJ. 2012;344:e1203.
8. Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int. 2014;86:162-167.
9. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311:579-586.
10. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2011 annual data report: kidney. Am J Transplant. 2013;13:11-46.
11. Roberts DA, Detre JA, Bolinger L, et al. Renal perfusion in humans: MR imaging with spin tagging of arterial water. Radiology. 1995;196:281-286.
12. Martirosian P, Klose U, Mader I, et al. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med. 2004;51:353-61.
13. Artz NS, Wentland AL, Sadowski EA, et al. Comparing kidney perfusion using noncontrast arterial spin labeling MRI and microsphere methods in an interven-tional swine model. Invest Radiol. 2011;46:124-131.
14. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxy-genation with BOLD MRI. Circulation. 1996;94:3271-3275.
15. Pedersen M, Dissing TH, Mørkenborg J, et al. Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int. 2005;67:2305-2312.
16. dos Santos EA, Li LP, Ji L, et al. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol. 2007;42:157-162.
17. Li LP, Ji L, Santos EA, et al. Effect of nitric oxide synthase inhibition on intra-renal oxygenation as evaluated by blood oxygenation level-dependent magnetic resonance imaging. Invest Radiol. 2009;44:67-73.
18. Warner L, Glockner JF, Woollard J, et al. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol. 2011;46:41-47.
19. 2 using an integrated approach of parametric magnetic resonance imaging and invasive physiological measurements. Invest Radiol. 2014; 49:547-560.
20. Zhang JL, Morrell G, Rusinek H, et al. Measurement of renal tissue oxygenation with blood oxygen level-dependent MRI and oxygen transit modeling.Am J Phys-iol Renal Physiol. 2014;306:F579-F587.
21. Li LP, Storey P, Pierchala L, et al. Evaluation of the reproducibility of intrarenal R2∗ and DeltaR2∗ measurements following administration of furosemide and during waterload. J Magn Reson Imaging. 2004;19:610-616.
22. Simon-Zoula SC, Hofmann L, Giger A, et al. Non-invasive monitoring of renal oxy-genation using BOLD-MRI: a reproducibility study. NMR Biomed. 2006;19:84-89.
23. Khatir DS, Pedersen M, Jespersen B, et al. Reproducibility of MRI renal artery blood flow and BOLD measurements in patients with chronic kidney disease and healthy controls. J Magn Reson Imaging. 2014;40:1091-1098.
24. Cutajar M, Thomas DL, Banks T, et al. Repeatability of renal arterial spin labelling MRI in healthy subjects. MAGMA. 2012;25:145-153.
25. Gillis KA, McComb C, Foster JE, et al. Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla. BMC Nephrol. 2014;15:23.
26. Thoeny HC, Zumstein D, Simon-Zoula S, et al. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology. 2006;241:812-821.
27. Artz NS, Sadowski EA, Wentland AL, et al. Arterial spin labeling MRI for assessment ofperfusion innative and transplanted kidneys. Magn Reson Imaging. 2011; 29:74-82.
28. Park SY, Kim CK, Park BK, et al. Evaluation of transplanted kidneys using blood oxygenation level-dependent MRI at 3 T: a preliminary study. Am J Roentgenol. 2012;198:1108-1114.
29. Sadowski EA, Fain SB, Alford SK, et al. Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: initial experience. Radiology. 2005;236:911-919.
30. Han F, Xiao W, Xu Y, et al. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrol Dial Transplant. 2008;23:2666-2672.
31. Djamali A, Sadowski EA, Muehrer RJ, et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol Renal Physiol. 2007;292:F513-F522.
32. Heusch P, Wittsack H-J, Blondin D, et al. Functional evaluation of transplanted kidneys using arterial spin labeling MRI. J Magn Reson Imaging. 2014;40:84-89.
33. Malvezzi P, Bricault I, Terrier N, et al. Evaluation of intrarenal oxygenation by blood oxygen level-dependent magnetic resonance imaging in living kidney donors and their recipients: preliminary results. Transplant Proc. 2009;41:641-644.
34. Vermathen P, Binser T, Boesch C, et al. Three-year follow-up of human transplanted kidneys by diffusion-weighted MRI and blood oxygenation level-dependent imaging. J Magn Reson Imaging. 2012;35:1133-1138.
35. Berl T. Renal protection by inhibition of the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst. 2009;10:1-8.
36. Hoogwerf BJ. Renin-angiotensin system blockade and cardiovascular and renal protection. Am J Cardiol. 2010;105:30A-35A.
37. de Bazelaire CM, Duhamel GD, Rofsky NM, et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology. 2004;230:652-659.
38. Pinheiro J, Bates D, DebRoy S, et al. NLME: linear and nonlinear mixed effects models. 2012. R package version 3.1-103. Available at: https://cran.r-project. org/web/packages/nlme/citation.html. Accessed February 18, 2015.
39. Fliser D, Zeier M, Nowack R, et al. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol. 1993;3:1371-1377.
40. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol. 1994;267:F1063-F1068.
41. Wentland AL, Artz NS, Fain SB, et al. MR measures of renal perfusion, oxygen bioavailability and total renal blood flow in a porcine model: noninvasive regional assessment of renal function. Nephrol Dial Transplant. 2012;27:128-135.
42. Poggio ED, Braun WE, Davis C. The science of stewardship: due diligence for kidney donors and kidney function in living kidney donation-evaluation, determinants, and implications for outcomes. Clin J Am Soc Nephrol. 2009;4: 1677-1684.
43. Mueller TF, Luyckx VA. The natural history of residual renal function in transplant donors. J Am Soc Nephrol. 2012;23:1462-1466.
44. Cutajar M, Hilton R, Olsburgh J, et al. Renal blood flow using arterial spin labelling MRI and calculated filtration fraction in healthy adult kidney donors pre-nephrectomy and post-nephrectomy. Eur Radiol. 2015;25:2390-2396.
45. Denton KM, Anderson WP, Sinniah R. Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. Am J Physiol Regul Integr Comp Physiol. 2000;279:R629-R638.
46. Loutzenhiser R, Hayashi K, Epstein M. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney. J Pharmacol Exp Ther. 1988;246:522-528.
47. Edwards RM, Trizna W, Kinter LB. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol. 1989;256:F274-F278.
48. Iñigo P, Campistol JM, Lario S, et al. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients. J Am Soc Nephrol. 2001;12:822-827.
49. Ripley E, Hirsch A. Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients? Int J Nephrol Renovasc Dis. 2010;3:93-98.
50. Kamper AL, Holstein-Rathlou NH, Strandgaard S, et al. Glomerular filtration rate and segmental tubular function in the early phase after transplantation/uninephrectomy in recipients and their living-related kidney donors. Clin Sci (Lond). 1994;87:519-523.
51. Hricak H, Terrier F, Demas BE. Renal allografts: evaluation by MR imaging. Radiology. 1986;159:435-441.
52. Huang Y, Sadowski EA, Artz NS, et al. Measurement and comparison of T1 relaxation times in native and transplanted kidney cortex and medulla. J Magn Reson Imaging. 2011;33:1241-1247.
53. Wang J, Alsop DC, Li L, et al. Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med. 2002;48: 242-254.
54. Gloviczki ML, Glockner J, Gomez SI, et al. Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease. Invest Radiol. 2009;44:566-571.